| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $554.0M | +4.1% |
| Cost of Revenue | $1.3M | -25.7% |
| Gross Profit | $240.8M | +15.5% |
| R&D Expense | $13.8M | +11.3% |
| SG&A Expense | $89.6M | -0.2% |
| Operating Income | $66.5M | +182.1% |
| Pre-tax Income | $58.7M | +204.1% |
| Income Tax | $18.7M | +101.9% |
| Net Income | $40.0M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $73.7M | +88.1% |
| Accounts Receivable | $7.7M | -54.3% |
| Current Assets | $334.4M | -5.7% |
| Total Assets | $1.26B | +9.3% |
| Current Liabilities | $99.1M | +3.2% |
| Long-term Debt | $113.0M | +65.0% |
| Total Liabilities | $288.8M | +25.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$25.3M | -38.0% |
| Capital Expenditures | $2.3M | +7.4% |
| Investing Cash Flow | $25.4M | +152.5% |
| Financing Cash Flow | $34.3M | +454.4% |
| Free Cash Flow | -$27.6M | -34.9% |
| +298.2% |
| EPS (Basic) | -$0.34 | +71.4% |
| EPS (Diluted) | -$0.34 | +71.4% |
| Stockholders' Equity |
| $591.6M |
| +0.5% |